CoreCap Advisors LLC Acquires 301 Shares of KKR & Co. Inc. (NYSE:KKR)

CoreCap Advisors LLC grew its holdings in KKR & Co. Inc. (NYSE:KKR) by 160.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 489 shares of the asset manager’s stock after purchasing an additional 301 shares during the period. CoreCap Advisors LLC’s holdings in KKR & Co. Inc. were worth $72,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of KKR. Vanguard Group Inc. grew its holdings in shares of KKR & Co. Inc. by 0.8% in the fourth quarter. Vanguard Group Inc. now owns 56,687,516 shares of the asset manager’s stock worth $8,384,650,000 after acquiring an additional 441,817 shares during the period. Geode Capital Management LLC lifted its position in KKR & Co. Inc. by 3.4% during the fourth quarter. Geode Capital Management LLC now owns 14,047,900 shares of the asset manager’s stock valued at $2,073,624,000 after purchasing an additional 458,048 shares in the last quarter. FMR LLC lifted its position in KKR & Co. Inc. by 6.7% during the fourth quarter. FMR LLC now owns 12,003,389 shares of the asset manager’s stock valued at $1,775,421,000 after purchasing an additional 752,056 shares in the last quarter. Norges Bank purchased a new position in KKR & Co. Inc. during the fourth quarter valued at $1,435,314,000. Finally, Northern Trust Corp lifted its position in KKR & Co. Inc. by 10.8% during the fourth quarter. Northern Trust Corp now owns 6,150,636 shares of the asset manager’s stock valued at $909,741,000 after purchasing an additional 600,696 shares in the last quarter. Institutional investors own 76.26% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts recently weighed in on KKR shares. Morgan Stanley lifted their target price on KKR & Co. Inc. from $114.00 to $120.00 and gave the company an “equal weight” rating in a research report on Monday, May 5th. Wells Fargo & Company boosted their price objective on KKR & Co. Inc. from $120.00 to $136.00 and gave the company an “overweight” rating in a research report on Friday, May 2nd. JMP Securities dropped their price objective on KKR & Co. Inc. from $165.00 to $150.00 and set a “market outperform” rating for the company in a research note on Tuesday, April 8th. TD Cowen dropped their price objective on KKR & Co. Inc. from $183.00 to $126.00 and set a “buy” rating for the company in a research note on Wednesday, April 9th. Finally, Citigroup dropped their price objective on KKR & Co. Inc. from $177.00 to $132.00 and set a “buy” rating for the company in a research note on Tuesday, April 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $147.00.

Insiders Place Their Bets

In other news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 5th. The stock was sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the transaction, the insider now owns 19,260,971 shares of the company’s stock, valued at approximately $634,841,604.16. This represents a 23.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Robert W. Scully bought 13,250 shares of the business’s stock in a transaction dated Tuesday, May 6th. The shares were acquired at an average cost of $113.49 per share, for a total transaction of $1,503,742.50. Following the purchase, the director now owns 13,250 shares of the company’s stock, valued at approximately $1,503,742.50. The trade was a ∞ increase in their position. The disclosure for this purchase can be found here. 39.34% of the stock is currently owned by insiders.

KKR & Co. Inc. Trading Up 1.3%

Shares of NYSE KKR opened at $126.89 on Wednesday. The business’s 50 day moving average is $111.32 and its two-hundred day moving average is $135.92. The company has a debt-to-equity ratio of 0.82, a current ratio of 0.07 and a quick ratio of 0.07. KKR & Co. Inc. has a 1-year low of $86.15 and a 1-year high of $170.40. The stock has a market capitalization of $112.71 billion, a P/E ratio of 38.11, a PEG ratio of 1.00 and a beta of 1.91.

KKR & Co. Inc. (NYSE:KKR) last issued its quarterly earnings data on Thursday, May 1st. The asset manager reported $1.15 earnings per share for the quarter, topping the consensus estimate of $1.13 by $0.02. KKR & Co. Inc. had a return on equity of 6.20% and a net margin of 14.31%. The company had revenue of $1.77 billion for the quarter, compared to analysts’ expectations of $1.71 billion. During the same period in the previous year, the firm posted $0.97 earnings per share. The firm’s revenue for the quarter was down 67.8% on a year-over-year basis. As a group, research analysts expect that KKR & Co. Inc. will post 5.19 EPS for the current year.

KKR & Co. Inc. Increases Dividend

The business also recently disclosed a dividend, which will be paid on Tuesday, May 27th. Shareholders of record on Tuesday, May 13th will be paid a dividend of $0.185 per share. This is a boost from KKR & Co. Inc.’s previous dividend of $0.17. This represents a yield of 0.64%. The ex-dividend date of this dividend is Monday, May 12th. KKR & Co. Inc.’s payout ratio is presently 31.22%.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.